TENELIGLIPTIN
TENELIGLIPTIN: TENELIGLIPTIN is an oral medication that belongs to the class of antidiabetic drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors. It is primarily prescribed for the treatment of type 2 diabetes mellitus.
Mechanism of Action:
TENELIGLIPTIN works by inhibiting the enzyme DPP-4, which is responsible for the breakdown of incretin hormones such as glucagon-like peptide-1 (GLP-1). By inhibiting DPP-4, TENELIGLIPTIN increases the levels of GLP-1 and glucose-dependent insulinotropic polypeptide (GIP), which helps stimulate insulin release and decrease glucagon secretion. This mechanism results in improved blood sugar control in individuals with type 2 diabetes.
Use:
TENELIGLIPTIN is prescribed as an adjunct to diet and exercise to help control blood sugar levels in adults with type 2 diabetes. It is typically used in combination with other antidiabetic medications such as metformin or insulin.
Dose:
The typical recommended dose of TENELIGLIPTIN is 20 mg once daily, taken orally with or without food. The dosage may be adjusted depending on an individual’s response and the advice of their healthcare provider. It is essential to adhere to the prescribed dosage and follow the instructions given by the doctor or pharmacist.
Side Effects:
Like any medication, TENELIGLIPTIN may cause some side effects. Common side effects include headache, nasopharyngitis (inflammation of the nasal passages and throat), urinary tract infection, upper respiratory tract infection, and back pain. These side effects are generally mild in nature and resolve on their own. Rarely, TENELIGLIPTIN may cause serious side effects such as pancreatitis (inflammation of the pancreas) or severe allergic reactions. It is important to seek immediate medical attention if any severe or persistent side effects occur.
It is crucial to talk to a healthcare provider before starting TENELIGLIPTIN, as it may interact with certain medications or have contraindications for certain medical conditions. Only a qualified healthcare professional can determine if TENELIGLIPTIN is suitable for a specific individual.